Matches in Wikidata for { <http://www.wikidata.org/entity/Q39652042> ?p ?o ?g. }
- Q39652042 description "2012 nî lūn-bûn" @default.
- Q39652042 description "2012年の論文" @default.
- Q39652042 description "2012年論文" @default.
- Q39652042 description "2012年論文" @default.
- Q39652042 description "2012年論文" @default.
- Q39652042 description "2012年論文" @default.
- Q39652042 description "2012年論文" @default.
- Q39652042 description "2012年论文" @default.
- Q39652042 description "2012年论文" @default.
- Q39652042 description "2012年论文" @default.
- Q39652042 description "2012年论文" @default.
- Q39652042 description "2012年论文" @default.
- Q39652042 description "2012年论文" @default.
- Q39652042 description "2012년 논문" @default.
- Q39652042 description "article científic" @default.
- Q39652042 description "article scientific" @default.
- Q39652042 description "article scientifique" @default.
- Q39652042 description "articol științific" @default.
- Q39652042 description "articolo scientifico" @default.
- Q39652042 description "artigo científico" @default.
- Q39652042 description "artigo científico" @default.
- Q39652042 description "artigo científico" @default.
- Q39652042 description "artikel ilmiah" @default.
- Q39652042 description "artikull shkencor" @default.
- Q39652042 description "artikulong pang-agham" @default.
- Q39652042 description "artykuł naukowy" @default.
- Q39652042 description "artículo científico publicado en 2012" @default.
- Q39652042 description "artículu científicu espublizáu en 2012" @default.
- Q39652042 description "bilimsel makale" @default.
- Q39652042 description "bài báo khoa học" @default.
- Q39652042 description "naučni članak" @default.
- Q39652042 description "scienca artikolo" @default.
- Q39652042 description "scientific article published on 14 February 2012" @default.
- Q39652042 description "scientific article published on 14 February 2012" @default.
- Q39652042 description "scientific article published on 14 February 2012" @default.
- Q39652042 description "teaduslik artikkel" @default.
- Q39652042 description "tieteellinen artikkeli" @default.
- Q39652042 description "tudományos cikk" @default.
- Q39652042 description "vedecký článok" @default.
- Q39652042 description "vetenskaplig artikel" @default.
- Q39652042 description "videnskabelig artikel" @default.
- Q39652042 description "vitenskapelig artikkel" @default.
- Q39652042 description "vitskapeleg artikkel" @default.
- Q39652042 description "vědecký článek" @default.
- Q39652042 description "wetenschappelijk artikel" @default.
- Q39652042 description "wissenschaftlicher Artikel" @default.
- Q39652042 description "επιστημονικό άρθρο" @default.
- Q39652042 description "мақолаи илмӣ" @default.
- Q39652042 description "наукова стаття, опублікована в лютому 2012" @default.
- Q39652042 description "научна статия" @default.
- Q39652042 description "научная статья" @default.
- Q39652042 description "научни чланак" @default.
- Q39652042 description "научни чланак" @default.
- Q39652042 description "מאמר מדעי" @default.
- Q39652042 description "مقالة علمية نشرت في 14 فبراير 2012" @default.
- Q39652042 description "১৪ ফেব্রুয়ারি ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q39652042 description "บทความทางวิทยาศาสตร์" @default.
- Q39652042 description "სამეცნიერო სტატია" @default.
- Q39652042 name "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 name "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 name "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 type Item @default.
- Q39652042 label "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 label "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 label "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 prefLabel "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 prefLabel "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 prefLabel "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 P1433 Q39652042-105AC7D6-D7E6-4576-A37D-F889F877038C @default.
- Q39652042 P1476 Q39652042-A7A8C62B-9C43-41BD-ABF5-BDD97D7E71FA @default.
- Q39652042 P2093 Q39652042-3048163D-9D50-4C82-8DC1-CDCC0672FA56 @default.
- Q39652042 P2093 Q39652042-77A80B12-B27B-41AA-B281-5E17DD35B7BE @default.
- Q39652042 P2093 Q39652042-86BC01AF-4DFE-450E-A800-53945BE1BF13 @default.
- Q39652042 P2093 Q39652042-9239E95F-BABE-4927-A09B-3EC5672941CF @default.
- Q39652042 P2093 Q39652042-A5EFD402-EE95-421C-B2B7-F59CC3F3B578 @default.
- Q39652042 P2093 Q39652042-C1BFD66D-4EFE-48F9-BBA0-E5A05B3BC48E @default.
- Q39652042 P2093 Q39652042-D5A89BF6-0822-4571-8245-ACCC430C5473 @default.
- Q39652042 P2093 Q39652042-F2DC2087-B324-4F25-B5EC-EA5EF9598084 @default.
- Q39652042 P304 Q39652042-C0813E26-AF98-4F77-BBD4-DA8BB53A8D41 @default.
- Q39652042 P31 Q39652042-58121687-28D5-49CC-8818-660732FA0F54 @default.
- Q39652042 P356 Q39652042-25251A87-3C13-4FB6-8AF3-8462E222CEF3 @default.
- Q39652042 P407 Q39652042-98E386CB-851D-4A44-AEAC-EB2271D5F303 @default.
- Q39652042 P433 Q39652042-479B4D56-0631-4848-A829-5487825BA83F @default.
- Q39652042 P478 Q39652042-BB680FEA-C8FE-483D-8418-0B6F7A00713E @default.
- Q39652042 P50 Q39652042-051197C3-A589-4D06-9BB5-F9B6F0AB068D @default.
- Q39652042 P50 Q39652042-2105BB5D-0AA5-4A68-B70C-E054903D6291 @default.
- Q39652042 P50 Q39652042-842EA1E6-ABA0-44EB-9B6D-6976EB50FAE8 @default.
- Q39652042 P50 Q39652042-983BDF24-369A-479D-9411-093FAF82DF69 @default.
- Q39652042 P50 Q39652042-DD82E9BD-8516-404C-9C3A-CF7803FA2358 @default.
- Q39652042 P50 Q39652042-F5BEB89E-E799-402F-8599-C17DC3413497 @default.
- Q39652042 P50 Q39652042-FDDCFFDA-0375-433F-BDD9-EE505F2D674E @default.
- Q39652042 P577 Q39652042-6C6F7A8A-21A1-4E90-8B49-6926890209EF @default.
- Q39652042 P698 Q39652042-97A7F329-086F-4E21-888A-96A800B0FF26 @default.
- Q39652042 P8608 Q39652042-05AF10E0-6897-4B3B-82CC-E3C9BA89FA2A @default.
- Q39652042 P921 Q39652042-A2EC5A27-7DDC-4A22-986F-E7FB6ACE7D6D @default.
- Q39652042 P356 1078-0432.CCR-11-2489 @default.
- Q39652042 P698 22338015 @default.
- Q39652042 P1433 Q332253 @default.
- Q39652042 P1476 "Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group" @default.
- Q39652042 P2093 "Biswaroop Mitra" @default.